Mark Wolff
Impact in
- Virology top 1%
- HIV Research and Treatment
- Epidemiology top 0.5%
- Influenza Virus Research Studies
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
Papers in
- Epidemiology 37
- Influenza Virus Research Studies 31
- Respiratory viral infections research 9
- Pneumonia and Respiratory Infections 5
- Virology 10
- HIV Research and Treatment 8
- Co-authors
- Robert B. Belshe (20 shared papers)John Jay Treanor (7 shared papers)Kenneth M. Zangwill (3 shared papers)Paul M. Mendelman (6 shared papers)James D. Campbell (3 shared papers)Thomas F. Rowe (2 shared papers)James C. King (7 shared papers)David I. Bernstein (10 shared papers)
- Journals
- The Journal of Infectious Diseases (17 papers)Vaccine (14 papers)New England Journal of Medicine (6 papers)The Pediatric Infectious Disease Journal (5 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United StatesMadagascarFrance
In The Last Decade
Mark Wolff
72 papers receiving 5.9k citations
Mark Wolff's Hit Papers
Peers
Comparison fields: 5 of 128
- Virology 762
- Epidemiology 4.0k
- Microbiology 658
- Infectious Diseases 1.7k
- Immunology 1.2k
Countries citing papers authored by Mark Wolff
This map shows the geographic impact of Mark Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wolff more than expected).
Fields of papers citing papers by Mark Wolff
This network shows the impact of papers produced by Mark Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wolff. The network helps show where Mark Wolff may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children Hit paper breakdown → | 1998 | 771 |
| 2 | Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine Hit paper breakdown → | 2006 | 632 |
| 3 | 2000 | 377 | |
| 4 | 2000 | 360 | |
| 5 | 2001 | 302 | |
| 6 | 1991 | 257 | |
| 7 | 2002 | 225 | |
| 8 | 2010 | 207 | |
| 9 | 2002 | 167 | |
| 10 | 1999 | 153 | |
| 11 | 2012 | 139 | |
| 12 | 2001 | 123 | |
| 13 | 1987 | 122 | |
| 14 | 2001 | 109 | |
| 15 | 2011 | 108 | |
| 16 | 2012 | 107 | |
| 17 | 2000 | 106 | |
| 18 | 2006 | 104 | |
| 19 | 1999 | 102 | |
| 20 | 2000 | 99 |
About Mark Wolff
Mark Wolff is a scholar working on Epidemiology, Virology, Microbiology, Infectious Diseases and Immunology, having authored 72 papers that have together received 6.5k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (31 papers), Respiratory viral infections research (9 papers), HIV Research and Treatment (8 papers), Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (5 papers), Syphilis Diagnosis and Treatment (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Virology (762 citations), Epidemiology (4.0k citations), Microbiology (658 citations), Infectious Diseases (1.7k citations) and Immunology (1.2k citations). Mark Wolff has collaborated with scholars based in United States, Madagascar and France. Frequent co-authors include Robert B. Belshe, John Jay Treanor, Kenneth M. Zangwill, Paul M. Mendelman, James D. Campbell, Thomas F. Rowe, James C. King, David I. Bernstein, William Gruber and Ken Zangwill. Their work appears in journals such as The Journal of Infectious Diseases, Vaccine, New England Journal of Medicine, The Pediatric Infectious Disease Journal and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.